Abstract:Background: Perfluorohexane sulfonate (PFHxS) is a frequently detected per- and polyfluoroalkyl substance in most populations, including in individuals who are pregnant, a period critical for early life development. Despite epidemiological evidence of exposure, developmental toxicity, particularly at realistic human exposures, remains understudied. Objectives: We evaluated the effect of gestational exposure to human-relevant body burden of PFHxS on fetal and placental development and explored mechanisms of action combining alternative splicing (AS) and gene expression (GE) analyses. Methods: Pregnant ICR mice were exposed to 0, 0.03, and 0.3 mu g / kg / day from gestational day 7 to day 17 via oral gavage. Upon euthanasia, PFHxS distribution was measured using liquid chromatography-tandem mass spectrometry. Maternal and fetal phenotypes were recorded, and histopathology was examined for placenta impairment. Multiomics was adopted by combining AS and GE analyses to unveil disruptions in mRNA quality and quantity. The key metabolite transporters were validated by quantitative real-time PCR (qRT-PCR) for quantification and three-dimensional (3D) structural simulation by AlphaFold2. Targeted metabolomics based on liquid chromatography-tandem mass spectrometry was used to detect amino acid and amides levels in the placenta. Results: Pups developmentally exposed to PFHxS exhibited signs of intrauterine growth restriction (IUGR), characterized by smaller fetal weight and body length (p < 0.01 ) compared to control mice. PFHxS concentration in maternal plasma was 5.01 +/- 0.54 ng / mL . PFHxS trans-placenta distribution suggested dose-dependent transfer through placental barrier. Histopathology of placenta of exposed dams showed placental dysplasia, manifested with an attenuated labyrinthine layer area and deescalated blood sinus counts and placental vascular development index marker CD34. Combined GE and AS analyses pinpointed differences in genes associated with key biological processes of placental development, proliferation, metabolism, and transport in placenta of exposed dams compared to that of control dams. Further detection of placental key transporter gene expression, protein structure simulation, and amino acid and amide metabolites levels suggested that PFHxS exposure during pregnancy led to impairment of placental amino acid transportation. Discussion: The findings from this study suggest that exposure to human-relevant very-low-dose PFHxS during pregnancy in mice caused IUGR, likely via downregulating of placental amino acid transporters, thereby impairing placental amino acid transportation, resulting in impairment of placental development. Our findings confirm epidemiological findings and call for future attention on the health risk of this persistent yet ubiquitous chemical in the early developmental stage and provide a new approach for understanding gene expression from both quantitative and qualitative omics approaches in toxicological studies.

Placental P-glycoprotein Inhibition Enhances Susceptibility to Di-(2-ethylhexyl)-phthalate Induced Cardiac Malformations in Mice: A Possibly Promising Target for Congenital Heart Defects Prevention

The Effect of Maternal Exposure to Di‐(2‐ethylhexyl)‐phthalate on Fetal Cardiac Development in Mice

Di-(2-ethylhexyl) Phthalate Exposure Induces Developmental Toxicity in the Mouse Fetal Heart via Mitochondrial Dysfunction

[Effect of Di-(2-ethylhexyl) Phthalate Exposure on Placental Development in Pregnant Mice].

Prenatal di-(2-ethylhexyl) phthalate exposure induced myocardial cytotoxicity via the regulation of the NRG1-dependent ErbB2/ErbB4-PI3K/AKT signaling pathway in fetal mice

Maternal Exposure to Di-(2-ethylhexyl) Phthalate Disrupts Placental Growth and Development in Pregnant Mice.

Exposure to Di-(2-ethylhexyl) Phthalate Reduces Secretion of GDNF Via Interfering with Estrogen Pathway and Downregulating ERK/c-fos Signaling Pathway in Astrocytes.

The Effect of 17Α-Ethynylestradiol Induced Intrahepatic Cholestasis of Pregnancy on Placental P-glycoprotein in Mice: Implications in the Individualized Transplacental Digoxin Treatment for Fetal Heart Failure

Di (2-ethyl-hexyl) phthalate disrupts placental growth in a dual blocking mode

Evaluating the Effect of Gestational Exposure to Perfluorohexane Sulfonate on Placental Development in Mice Combining Alternative Splicing and Gene Expression Analyses

Prenatal triphenyl phosphate exposure impairs placentation and induces preeclampsia-like symptoms in mice

Specific Effects of Prenatal DEHP Exposure on Neuroendocrine Gene Expression in the Developing Hypothalamus of Male Rats

Reproductive Hazards of Di-(2-ethylhexyl)-phthalate: in Vitro and in Vivo Exposure to Mouse

Effects of DEHP on Endometrial Receptivity and Embryo Implantation in Pregnant Mice

The Effects of Di-(2-ethylhexyl)-phthalate Exposure on Fertilization and Embryonic Development in Vitro and Testicular Genomic Mutation in Vivo

Compartmentalized regulation of NAD+ by Di (2-ethyl-hexyl) phthalate induces DNA damage in placental trophoblast

Transgenerational Effects of Di(2-Ethylhexyl) Phthalate on Anogenital Distance, Sperm Functions and DNA Methylation in Rat Offspring

Gestational Perfluorooctanoic Acid Exposure Inhibits Placental Development by Dysregulation of Labyrinth Vessels and Unk Cells and Apoptosis in Mice.

Di-2-ethylhexyl phthalate-induced miR-155–5p promoted lipid metabolism via inhibiting cAMP/PKA signaling pathway in human trophoblastic HTR-8/Svneo cells

Effects of Di(2-ethylhexyl) Phthalate(dehp) on Mouse Embryos Development in Vitro

Disruption Of Reproductive Development In Male Rat Offspring Following Gestational And Lactational Exposure To Di-(2-Ethylhexyl) Phthalate And Genistein